Literature DB >> 26250794

Evaluation of oral prophylaxis during and after intensity-modulated radiotherapy due to head and neck cancer--a retrospective study.

D Bichsel1, M Lanfranchi2, T Attin2, K W Grätz2, B Stadlinger2.   

Abstract

OBJECTIVES: The aim of this study was to retrospectively analyze the influence of a prophylaxis protocol of head and neck tumor (HNT) patients during and after intensity-modulated radiotherapy (IMRT). MATERIAL AND
METHOD: In this 5-year retrospective study (2009-2013), 70 (m 55, f 15; age range 28-8 years; median 58.7 years) out of 248 HNT patients of the Clinic of Cranio-Maxillofacial and Oral Surgery at the University of Zurich, Switzerland, fulfilled the inclusion criteria. Parameters of investigation were the salivary flow rates, possible dental foci and the dental status, oral side effects of radiotherapy, the prophylaxis protocol, and patient's compliance to this protocol. The following time points before during and after IMRT (6 weeks) were analyzed: prior to IMRT, 2-4 weeks, 6 weeks and 3, 6, and 12 months after the onset of radiotherapy. RESULT: Unstimulated salivary flow rate, pH value of unstimulated salivary, and stimulated salivary flow rate showed a significant reduction over time (p < 0.001). One year after IMRT, both unstimulated and stimulated salivary flow showed a statistically significant lower salivary flow. The number of caries-affected sites per patient was significantly higher for patients with low compliance to the prophylaxis protocol (mean: low compliance 1.36, high compliance 0.26). Almost 75% of the evaluated patients suffered immediate gustatory change, and 47.1% showed signs of radiostomatitis through IMRT.
CONCLUSIONS: High compliance to the prophylaxis protocol during and after radiotherapy is a key factor for the reduction of radiation side effects on dental hard tissue. CLINICAL RELEVANCE: High compliance to a monitored prophylaxis program is crucial for patients after head and neck surgery.

Entities:  

Keywords:  Compliance; Head and neck tumor; Prophylaxis; Radiotherapy; Salivary flow parameters

Mesh:

Year:  2015        PMID: 26250794     DOI: 10.1007/s00784-015-1546-9

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  27 in total

1.  [Dental care for patients with antineoplastic radiotherapy of the head and neck].

Authors:  K A Grötz
Journal:  Strahlenther Onkol       Date:  2003-04       Impact factor: 3.621

2.  Three-dimensional conformal vs. intensity-modulated radiotherapy in head-and-neck cancer patients: comparative analysis of dosimetric and technical parameters.

Authors:  Luca Cozzi; Antonella Fogliata; Alessandra Bolsi; Giorgia Nicolini; Jacques Bernier
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-02-01       Impact factor: 7.038

3.  Intensity-modulated radiation therapy in head and neck cancers: dosimetric advantages and update of clinical results.

Authors:  Dev R Puri; William Chou; Nancy Lee
Journal:  Am J Clin Oncol       Date:  2005-08       Impact factor: 2.339

4.  Risk-adapted dental care prior to intensity-modulated radiotherapy (IMRT).

Authors:  Gabriela Studer; Christoph Glanzmann; Stephan P Studer; Klaus W Grätz; Marius Bredell; Michael Locher; Urs M Lütolf; Roger A Zwahlen
Journal:  Schweiz Monatsschr Zahnmed       Date:  2011

5.  Prevention of xerostomia-related dental caries in irradiated cancer patients.

Authors:  S Dreizen; L R Brown; T E Daly; J B Drane
Journal:  J Dent Res       Date:  1977-02       Impact factor: 6.116

6.  Effects of compliance with fluoride gel application on caries and caries risk in patients after radiation therapy for head and neck cancer.

Authors:  J B Epstein; E H van der Meij; R Lunn; P Stevenson-Moore
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1996-09

Review 7.  Oral management of patients following oncology treatment: literature review.

Authors:  M J Shaw; N D Kumar; M Duggal; J Fiske; D A Lewis; T Kinsella; T Nisbet
Journal:  Br J Oral Maxillofac Surg       Date:  2000-10       Impact factor: 1.651

8.  Long-term oral Candida colonization, mucositis and salivary function after head and neck radiotherapy.

Authors:  K A Grötz; S Genitsariotis; D Vehling; B Al-Nawas
Journal:  Support Care Cancer       Date:  2003-08-09       Impact factor: 3.603

9.  Postoperative IMRT in head and neck cancer.

Authors:  Gabriela Studer; Katrin Furrer; Bernard J Davis; Sandro S Stoeckli; Roger A Zwahlen; Urs M Luetolf; Christoph Glanzmann
Journal:  Radiat Oncol       Date:  2006-10-19       Impact factor: 3.481

10.  The treatment outcome and radiation-induced toxicity for patients with head and neck carcinoma in the IMRT era: a systematic review with dosimetric and clinical parameters.

Authors:  Vassilis Kouloulias; Stella Thalassinou; Kalliopi Platoni; Anna Zygogianni; John Kouvaris; Christos Antypas; Efstathios Efstathopoulos; Kelekis Nikolaos
Journal:  Biomed Res Int       Date:  2013-10-22       Impact factor: 3.411

View more
  4 in total

1.  FDG-PET/CT for oral focus assessment in head and neck cancer patients.

Authors:  Dominic Raphael Schwaninger; Martin Hüllner; Dominique Bichsel; Barbara Giacomelli-Hiestand; Nicole Selina Stutzmann; Panagiotis Balermpas; Silvio Valdec; Bernd Stadlinger
Journal:  Clin Oral Investig       Date:  2022-03-07       Impact factor: 3.606

Review 2.  Should oral foci of infection be removed before the onset of radiotherapy or chemotherapy?

Authors:  Fred K L Spijkervet; Jennifer M Schuurhuis; Monique A Stokman; Max J H Witjes; Arjan Vissink
Journal:  Oral Dis       Date:  2020-06-01       Impact factor: 3.511

3.  Including dental professionals in the multidisciplinary treatment team of head and neck cancer patients improves long-term oral health status.

Authors:  Kristina Bertl; Philippe Savvidis; Edmund Benjamin Kukla; Steffen Schneider; Konstantin Zauza; Corinna Bruckmann; Andreas Stavropoulos
Journal:  Clin Oral Investig       Date:  2021-11-18       Impact factor: 3.573

4.  Value of FDG-PET/MR in Oral Focus Assessment in Head and Neck Cancer Patients-A Feasibility Study.

Authors:  Silvio Valdec; Fabienne A Bosshard; Martin Hüllner; Dominic R Schwaninger; Larissa Stocker; Barbara Giacomelli-Hiestand; Bernd Stadlinger
Journal:  Front Med (Lausanne)       Date:  2022-03-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.